Concord Drugs VS Pharmaceuticals & Biotechnology 
1D
4.9%
0.06%
1W
6.32%
-0.12%
1M
5.4%
1.25%
YTD
-9.43%
-7.84%
1Y
36.49%
-1.65%
3Y
122.06%
19.57%
5Y
176.67%
43.97%
10Y
21.46%
182.78%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.35%
0%
-8.35%
6 Months
-7.16%
0%
-7.16%
1 Year
36.49%
0%
36.49%
2 Years
114.04%
0%
114.04%
3 Years
122.06%
0%
122.06%
4 Years
175.14%
0%
175.14%
5 Years
176.67%
0%
176.67%
Concord Drugs for the last several years.
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
3
Quartile
QTD
-2.86%
4
Quartile
Mar-Jun
9.5%
3
Quartile
Dec-Mar
-14.85%
2
Quartile
YTD
39.26%
1
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the YTD and longer periods
3
Quartile
QTD
-2.86%
4
Quartile
Mar-Jun
9.5%
2
Quartile
Dec-Mar
-14.85%
1
Quartile
YTD
39.26%
1
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXRisk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
